India's Gufic Biosciences up on Australia, Brazil nod for parecoxib injection

Gufic Biosciences

12/09/2023 07:19

** Shares of Gufic Biosciences  GUFI.NS  rise as much as
7.6% to 319.2 rupees, biggest pct gain since July 27
    ** Co receives regulatory approval for Parecoxib 40 mg
injection from Australia's TGA and Brazil's Anvisa 
    ** Injection to be used for short-term treatment of acute
pain and post-operative pain in adult patients
    ** More than 804,930 shares change hands by 11:20 a.m. IST, 
2.0x the 30-day avg of 402,502 shares
    ** Stock last up 2.6%, bumping YTD gains to ~33% 


 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))